The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating tumor DNA analysis (ctDNA) for genomic testing in NSCLC patients with isolated CNS progression.
 
Mihaela Aldea
No Relationships to Disclose
 
Laura Mezquita
No Relationships to Disclose
 
Lizza Hendriks
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Roche/Genentech (Inst)
Speakers' Bureau - Quadia
Research Funding - Bristol-Myers Squibb (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche/Genentech
Other Relationship - AstraZeneca
 
Edouard Auclin
No Relationships to Disclose
 
Jordi Remon
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Pfizer
Travel, Accommodations, Expenses - Inivata; OSE Immunotherapeutics; OSE Immunotherapeutics; Roche/Genentech
 
David Planchard
Honoraria - PeerVoice; Prime Oncology
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; MedImmune; MSD Oncology; Novartis; Pfizer; Roche
Research Funding - Abbvie (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi/Aventis (Inst); Taiho Pharmaceutical (Inst)
 
Cecile Jovelet
No Relationships to Disclose
 
Jose Carlos Benitez
No Relationships to Disclose
 
Anas Gazzah
Consulting or Advisory Role - Novartis
Research Funding - Aduro Biotech; Agios; Amgen; arGEN-X BVBA; Arno Therapeutics; Astex Pharmaceuticals; AstraZeneca; AVEO; Bayer; BBB Technologies; BeiGene; BioAlliance Pharma; BioNTech; Blueprint Medicines; BMS Brazil; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Chugai Pharma; Clovis Oncology; Daiichi Sankyo; Debiopharm Group; Eisai; Exelixis; FORMA Therapeutics; GamaMabs Pharma; Genentech; Gilead Sciences; GlaxoSmithKline; Glenmark; H3 Biomedicine; Incyte; Innate Pharma; Institut de Recherches Internationales Servier; Janssen-Cilag; Kura Oncology; Kyowa Hakko Kirin; Lilly; Loxo; Lytix Biopharma; MedImmune; Menarini; Merck; Merck Sharp & Dohme Chibret; Merrimack; Merus; Millennium; Nanobiotix; Nektar; Novartis; Novartis Pharmaceuticals UK Ltd.; Octimet; Oncoethix; OncoMed; Oncopeptides; Onyx; Orion; Oryzon Genomics; Pfizer; Pharma Marathi; Pierre Fabre; RigonTEC; Roche; Roche Pharma AG; Sanofi; Sierra Oncology; Taiho Pharmaceutical; Tesaro; Tioma Therapeutics; Xencor
Travel, Accommodations, Expenses - Boehringer Ingelheim; Novartis; Pfizer; Roche
 
Pernelle Lavaud
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Ipsen; Janssen
 
Charles Naltet
No Relationships to Disclose
 
Ludovic Lacroix
No Relationships to Disclose
 
Clive D. Morris
Employment - Inivata
Leadership - Inivata
Stock and Other Ownership Interests - Inivata
 
Emma Green
Employment - Inivata
Stock and Other Ownership Interests - Inivata
Travel, Accommodations, Expenses - Inivata
 
Karen Howarth
Employment - Inivata
Stock and Other Ownership Interests - Inivata
Research Funding - Inivata
Patents, Royalties, Other Intellectual Property - Patent pending
 
Claudio Nicotra
No Relationships to Disclose
 
Benjamin Besse
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Biogen (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Ignyta (Inst); Inivata (Inst); Ipsen (Inst); Lilly (Inst); Merck KGaA (Inst); MSD Oncology (Inst); Nektar (Inst); Onxeo (Inst); Pfizer (Inst); PharmaMar (Inst); Sanofi (Inst); Spectrum Pharmaceuticals (Inst); Takeda (Inst); Tiziana Therapeutics (Inst)